Portals and mobile applications that can effectively reduce medication costs are highly desired by both consumers and businesses. “Medication optimization,” pioneered by RxREVU, is a practical way to help you attract new users to your application.
● Gain users by delivering huge savings on medications
● Help self-insureds lower their pharmacy benefit costs
● Save time and money by licensing instead of building
● Increase application usage with appeals to save money
● Profit by partnering with us and reselling our data
Employers and payers are looking to reduce their pharmacy benefit costs. Lack of comparison shopping is a large contributor to the high cost of healthcare. Platforms with “save money on your medication” appeals will increase usage, mobile downloads, engagement, and retention. In the consumer marketplace, mobile apps that can pass along real savings to consumers will become market leaders.
By providing medication savings research inside your portal or mobile application, you'll be appealing to one of the most urgent and widespread problems in healthcare. Consumers are desperately seeking ways to afford their medication, and our data can help your platform, portal, or mobile application attract and retain these consumers.
Comprehensive and Continually Updated + Research Footnotes
We provide comprehensive dosage information that allows the doctor to feel comfortable and empowered to change the prescription. This unique aspect of our data is critical to drive adoption and achieve savings at the point of contact between patients and their doctors. Without dosage equivalency data, doctors may not feel comfortable prescribing a cost saving alternative. RxREVU is the only dataset that provides dosage equivalency information critical to driving adoption.
RxREVU recommendations utilize expert opinions drawn from peer-reviewed evidence-based research reviews published on PubMed, the world's largest scientific research database and other national peer reviewed medical journals. Recommendations are also drawn from the 2,736 "national guideline" summaries, available from the National Guideline Clearinghouse website of the Agency for Healthcare Research and Quality of the US Department of Health and Human Services.
Our data can be formatted into a printable report that serves a number of useful purposes. First, by having a printable report, the user can then bring this report to their doctor, to discuss their potential medication optimization. Our dataset contains two two fields that we call "narratives." One is directed at the patient, and explains the optimization in plain English. This "patient narrative" explains the basis of the optimization and tells them why this optimization might be a good option, without confusing medical jargon.
The other narrative is directed to the doctor, and is designed to help them quickly understand the implications of the optimization, in medical terms (including clinical references and peer reviewed studies). By addressing both audiences, with targeted narratives, the likelihood for a cost-reducing switch being adopted goes up dramatically. Without these narratives, no context is given to what otherwise could be a very appropriate and medically sound way for a patient to save money on their medications. RxREVU is the only dataset on the market today that provides doctor and patient narratives, which ultimate drive adoption and lead to lower costs.
Example "Patient Narrative" for The Drug: Uloric
You are paying extra for a once daily medication. The old medication works in the same way but is three times per day. If you are OK with the trade-off it could cost you much less per year. Discuss with your provider.
Example "Doctor Narrative" for The Drug: Uloric
There is no generic. Uloric is a once daily "xanthine oxidase inhibitor". The cost-effective alternative would be to use allopurinol, the generic of Zyloprim, the original three times daily xanthine oxidase inhibitor. Consider use of: allopurinol 100 mg three times daily. Because retail is only $10 per month, do not use your co-pay card if it would cost you more.
And We Only Applied 5% Of Our Dataset...
Aetna provided RxREVU with specialized access to “de-identified” claims data from its members, so that we could apply our medication optimization strategies to validate the effectiveness of our research to reduce prescription drug costs for a large population. The claims we analyzed contained information from more than 16 million recent prescriptions across 10 million patient lives.
The enormous savings we generated didn't even include all of our recommendations, just the top 100, out of 2000. Our research seeks out inefficiencies and provides several innovative strategies to reduce cost while addressing quality. By offering our research inside your healthcare portal or application, you can generate substantial savings for your users, regardless of whether they're patients or payers.
Saving patients money can change lives...
My generics only plan from United Healthcare cost me $260/month because I was on a brand name drug and had to pay retail. RxRevu identified a similar generic that had the same effectiveness and would only cost me $40 per month, saving me $2,640/year. I couldn’t be happier!
As a Type 1 diabetic, I buy insulin every month. Originally, I was on Novolog, which was costing me around $115 per month. RxREVU identified Humalog as a possible alternative, my doctor made the switch, and now I only pay $35 a month. I recommend your site to friends quite often. Thanks.
Increase The Appeal Of Your Application With Our Cost Optimization Dataset
Pharmacy benefits are a large burden on payers, both directly and indirectly. The rising cost of pharmacy benefits and expensive speciality drugs are making payers desperate for solutions.
Healthcare platform vendors that can directly lower these costs or can pass along new reductions to their clients will greatly increase their value, market share, and profitability. RxREVU can provide the data and quality and cost research to help your application meet the needs of both end users and your large enterprise customers.
By adding our optimization data to your healthcare application, you can increase usage and adoption by appealing to patients' overwhelming need to save money on their medications. Plus, our doctor and patient narratives give your application a way to engage consumers in a way that makes them feel excited and empowered, which results in lower costs for everyone.
In addition, select partners can qualify to become a Value Added Reseller and earn additional revenue for their business by reselling our data to your existing and future clients. Our data is licensed through a revenue share, which means you are free to price the data according to your current PMPM or other pricing practices.
● Cost Transparency Apps
● Eduction Pre/Post-Diagnosis
● Filling Prescription Apps
● Compliance & Medication Adherence
● Patient Health Records (PHR)
● Wellness Applications
● Electronic Medical/Health Record (EMR/EHR)
● Benefit Management Groups
Embed Our Data In Your Application In Just A Matter Of Days
Our API is robust, yet easy to work with. We offer two types of authentication, API Key and OAuth. Traditional API Key authentication is the fastest to implement, which means your application can be displaying RxREVU data in just a matter of days, if not hours.
Bottom Line: Our medication optimization data can quickly and easily be integrated into your organization’s existing platforms and portals and requires only a standard licensing agreement. Easy to integrate, continuously updated and expanded, our data will instantly add value to your healthcare platform or mobile application. Contact us today to explore your needs...
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form :(
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo...
Read more ›Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo...
Read more ›Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo...
Read more ›